In addition to CDI, hypopituitarism was observed in 68% of the patients, including growth hormone and IGF-1 deficiency, hypogonadotropic hypogonadism, central hypothyroidism, hyperprolactinemia, and cortisol deficiency. This evidence concerns the gene GH1 and hypopituitarism.